Articles |
From the Departments of Anesthesiology (R.E.L.), Molecular Physiology and Biological Physics (R.E.L., A.P.S., G.K.O., A.V.S.), Medicine (A.P.S.), and Pathology (A.V.S.), University of Virginia Health Sciences Center, Charlottesville.
Correspondence to Ryan E. Lesh, MD, Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Box 449, Charlottesville, VA 22908.
Abstract Antisense oligodeoxynucleotides (ODNs) have been used to modify gene expression in vitro and are also promising therapeutic agents. Although there are numerous reports of antisense ODNmediated changes in protein expression of cultured cells, use of these compounds to achieve antisense regulation of specific proteins in intact tissue has been limited. The aims of this study were (1) to define organ culture conditions for ileum smooth muscle that would permit long-term maintenance of force-generating capabilities and normal ultrastructure and (2) to develop a method for efficient introduction of antisense ODNs into intact tissue. Sheets of ODN-containing, reversibly permeabilized rat outer longitudinal ileum were maintained in a serum-free organ culture medium for 1 week without significant decreases in tension response to membrane depolarization or carbachol stimulation; the G proteincoupled calcium sensitization pathway was also intact after 7 days. Reversible permeabilization, a method previously used to load smooth and cardiac muscle with aequorin and heparin, was effective for loading >95% of ileum smooth muscle cells with a fluorescein-conjugated antisense ODN (5'-AAGGGCCATTTTGTT-FITC-3'). Confocal microscopy of reversibly permeabilized smooth muscle loaded with fluorescent antisense ODNs revealed intense nuclear fluorescence and less intense, homogeneous, cytoplasmic fluorescence. Internally radiolabeled ODNs (homologous to the above sequence) showed complete degradation between 4 and 16 hours after introduction into the cells. In summary, we have demonstrated methods for long-term organ culture and high-efficiency introduction of antisense ODNs into intact smooth muscle sheets. Such methods have broad potential utility for investigating many questions in smooth muscle biology. At present, however, a major limitation of this approach is the short half-life of phosphorothioated ODNs.
Key Words: antisense oligodeoxynucleotides smooth muscle reversible permeabilization confocal microscopy electron microscopy
This article has been cited by other articles:
![]() |
J. P. Bannister, A. Adebiyi, G. Zhao, D. Narayanan, C. M. Thomas, J. Y. Feng, and J. H. Jaggar Smooth Muscle Cell {alpha}2{delta}-1 Subunits Are Essential for Vasoregulation by CaV1.2 Channels Circ. Res., November 6, 2009; 105(10): 948 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nystoriak, K. Murakami, P. L. Penar, and G. C. Wellman Cav1.2 splice variant with exon 9* is critical for regulation of cerebral artery diameter Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1820 - H1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Fomin, A. Kronbergs, S. Gunst, D. Tang, V. Simirskii, M. Hoffman, and R. L. Duncan Role of Protein Kinase C{alpha} in Regulation of [Ca2+]I and Force in Human Myometrium Reproductive Sciences, January 1, 2009; 16(1): 71 - 79. [Abstract] [PDF] |
||||
![]() |
C. Morin, M. Sirois, V. Echave, and E. Rousseau CPI-17 Silencing-Reduced Responsiveness in Control and TNF-{alpha}-Treated Human Bronchi Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xi, A. Adebiyi, G. Zhao, K. E. Chapman, C. M. Waters, A. Hassid, and J. H. Jaggar IP3 Constricts Cerebral Arteries via IP3 Receptor-Mediated TRPC3 Channel Activation and Independently of Sarcoplasmic Reticulum Ca2+ Release Circ. Res., May 9, 2008; 102(9): 1118 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Corteling, S. E. Brett, H. Yin, X.-L. Zheng, M. P. Walsh, and D. G. Welsh The functional consequence of RhoA knockdown by RNA interference in rat cerebral arteries Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H440 - H447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, S. V. Straub, and J. E. Brayden Protein kinase C regulates vascular myogenic tone through activation of TRPM4 Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2613 - H2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. J. Heppner, M. T. Nelson, and J. E. Brayden TRPV4 Forms a Novel Ca2+ Signaling Complex With Ryanodine Receptors and BKCa Channels Circ. Res., December 9, 2005; 97(12): 1270 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Reading, S. Earley, B. J. Waldron, D. G. Welsh, and J. E. Brayden TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2055 - H2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Amberg, C. F. Rossow, M. F. Navedo, and L. F. Santana NFATc3 Regulates Kv2.1 Expression in Arterial Smooth Muscle J. Biol. Chem., November 5, 2004; 279(45): 47326 - 47334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, B. J. Waldron, and J. E. Brayden Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries Circ. Res., October 29, 2004; 95(9): 922 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen and R. J. Lechleider Transforming Growth Factor-{beta}-Induced Differentiation of Smooth Muscle From a Neural Crest Stem Cell Line Circ. Res., May 14, 2004; 94(9): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohama, M. Hori, K. Sato, H. Ozaki, and H. Karaki Chronic Treatment with Interleukin-1{beta} Attenuates Contractions by Decreasing the Activities of CPI-17 and MYPT-1 in Intestinal Smooth Muscle J. Biol. Chem., December 5, 2003; 278(49): 48794 - 48804. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muraki, Y. Iwata, Y. Katanosaka, T. Ito, S. Ohya, M. Shigekawa, and Y. Imaizumi TRPV2 Is a Component of Osmotically Sensitive Cation Channels in Murine Aortic Myocytes Circ. Res., October 31, 2003; 93(9): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Welsh, A. D. Morielli, M. T. Nelson, and J. E. Brayden Transient Receptor Potential Channels Regulate Myogenic Tone of Resistance Arteries Circ. Res., February 22, 2002; 90(3): 248 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-D. Je, S. S Gangopadhyay, T. D Ashworth, and K. G Morgan Calponin is required for agonist-induced signal transduction - evidence from an antisense approach in ferret smooth muscle J. Physiol., December 1, 2001; 537(2): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kim, H.-D. Je, C. Gallant, Q. Zhan, D. V. Riper, J. A Badwey, H. A Singer, and K. G Morgan Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta J. Physiol., July 15, 2000; 526(2): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lindqvist, I. Nordstrom, U. Malmqvist, P. Nordenfelt, and P. Hellstrand Long-term effects of Ca2+ on structure and contractility of vascular smooth muscle Am J Physiol Cell Physiol, July 1, 1999; 277(1): C64 - C73. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Earley, X. Su, and R. S. Moreland Caldesmon Inhibits Active Crossbridges in Unstimulated Vascular Smooth Muscle : An Antisense Oligodeoxynucleotide Approach Circ. Res., September 21, 1998; 83(6): 661 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujihara, L. A. Walker, M. C. Gong, E. Lemichez, P. Boquet, A. V. Somlyo, and A. P. Somlyo Inhibition of RhoA Translocation and Calcium Sensitization by In Vivo ADP-Ribosylation with the Chimeric Toxin DC3B Mol. Biol. Cell, December 1, 1997; 8(12): 2437 - 2447. [Abstract] [Full Text] |
||||
![]() |
M. Gomez and K. Sward Long-term regulation of contractility and calcium current in smooth muscle Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1714 - C1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Welsh, A. D. Morielli, M. T. Nelson, and J. E. Brayden Transient Receptor Potential Channels Regulate Myogenic Tone of Resistance Arteries Circ. Res., February 22, 2002; 90(3): 248 - 250. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |